Don't miss a thing!

OUR NEWS AND VIEWS

SHARING LATEST
DEVELOPMENTS AND INSIGHTS

Here we report on topics relating to digital medical publishing and our business. These include our research reports, whitepapers and thought-leadership, as well as our latest programmes, engagement insights, industry partnerships and team recruits.

Nov 2023

Webinar recording: Cutting Through the Noise with Impactful HCP Education

This MedComms Networking webinar saw EPG Health collaborate with a panel of industry experts to discuss new research into HCP content and channel preferences for medical education, and approaches to measuring meaningful outcomes.

ACCESS THE RECORDING

Nov 2023

NEW RESEARCH REPORT: The Future of HCP Engagement Impact

Understanding HCP needs and behaviour and developing meaningful impact metrics are among pharma’s top HCP engagement priorities for 2024, EPG Health’s latest research reveals.

Learn More

Sep 2023

Celebrating best practice at the PM Society Digital Awards

EPG Health was recognised by the PM Society at its Digital Awards in London on 14 September. The independent Supportive Care in Oncology Learning Zone, hosted on Medthority, was a finalist in the HCP Education category.

Learn More

Featured article

Thought Leadership

Creating an award-winning HCP engagement platform

EPG Health’s pioneering approach to…

Learn More

Jan 2023

May 2023

Supportive Care in Oncology programme drives knowledge change

Overwhelming intent to change clinical practice has been recorded among healthcare professionals engaging with a Supportive Care in Oncology Learning Zone hosted on Medthority.

Learn More

May 2023

Growth Hormone Deficiency Learning Zone launches on Medthority

HCPs will gain understanding of growth hormone deficiency and appropriate treatment options after engaging with this educational programme, developed independently of sponsor Sandoz.

View the Learning Zone

May 2023

Programme goes live: Anti-CGRP therapies for migraine

Developed with an educational grant from Pfizer, this Learning Zone includes focus on the unmet needs and disease burden associated with migraine and anti-CGRP therapies for acute and prophylactic treatment.

View the Learning Zone